The Aventa FusionPlus test incorporates 3D genomics technology, leveraging preservation of the spatial proximity of fused and ...

You were born special,” Heather Horne told her 3-year-old daughter. “You were born without bone, and the doctor is gonna put ...

Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders On track to report topline data from the RewinD-LB ...

Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...

intraneuronal inclusions in those two regions of the brain containing either the protein tau or TDP-43 (transactive response DNA binding protein); intranuclear inclusions of fused in sarcoma (FUS ...

D Bioprinting Market. The global 3D bioprinting market is projected to reach USD 2.24 billion by 2024, with demand expected ...

Alan Herbert, President of InsideOutBio, guides us through targeting the most complex flipon of them all in the fight against ...

Nov. 27, 2024 — Researchers have used a new gold-based drug to slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a new ...